Terms ending in 2027
Every in-force patent on F. Hoffmann-La Roche AG's record whose computed term ends in 2027, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 7,425,551 | Malonamide Derivatives In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US D678,998 | Medical Dispensing Device In force · High confidence | F. Hoffmann-La Roche AG | In force | High confidence | |
| US 7,514,426 | Substituted Imidazol[1,5-a][1,2,4]triazolo[1,5-d][1,4]benzodiazepine Derivatives In force · Medium confidence | Hoffmann-La Roche Inc. | In force | Medium confidence | |
| US 8,450,315 | Phosphoinositide 3-Kinase Inhibitor Compounds and Methods of Use In force · Medium confidence | Genentech, Inc. | In force | Medium confidence | |
| US 7,867,452 | Multi-Well Filtration Device In force · High confidence | F. Hoffmann-La Roche AG | In force | High confidence | |
| US 7,438,861 | Heatable Pipette In force · High confidence | F. Hoffmann-La Roche AG | In force | High confidence | |
| US 7,586,612 | Photometric Analysis of Biological Samples Using In-Plane Detection In force · High confidence | Roche Diagnostics Operations, Inc. | In force | High confidence | |
| US 8,324,206 | Pharmaceutical Compounds In force · Medium confidence | F. Hoffmann-La Roche AG | In force | Medium confidence | |
| US 7,504,544 | Asymmetric Hydrogenation of 1,1,1- Trifluoroacetone In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 7,642,264 | Phenyl-Substituted Pyrimidine Derivatives as MG1UR Antagonists In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| 6 more term ends in 2027 · Pro | |||||
10 of 16 patents shown. Soonest term end first, then patent number.
Pro members see all 16, all of them expiring within the 18 months from Nov 19, 2026.
6 of these are in force and held by F. Hoffmann-La Roche AG.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.